Edition:
United States

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

425.50SEK
12:29pm EDT
Change (% chg)

-14.50kr (-3.30%)
Prev Close
440.00kr
Open
441.00kr
Day's High
441.00kr
Day's Low
425.50kr
Volume
14,276
Avg. Vol
28,858
52-wk High
559.00kr
52-wk Low
318.00kr

VITR.ST

Chart for VITR.ST

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.73
Market Cap(Mil.): kr9,552.45
Shares Outstanding(Mil.): 21.71
Dividend: 2.60
Yield (%): 0.59

Financials

  VITR.ST Industry Sector
P/E (TTM): 50.18 33.98 29.72
EPS (TTM): 8.77 -- --
ROI: 18.98 12.74 13.00
ROE: 20.46 14.80 14.15

BRIEF-Vitrolife Q4 core profit rose to SEK 96 mln

* Q4 sales amounted to SEK 251 (199) million, corresponding to an increase of 26 percent in SEK. Net sales growth was 21 percent in local currency.

Feb 09 2017

BRIEF-Vitrolife wins order in Japan for 8 EmbryoScope+ time-lapse incubators

* Kato ladies clinic chooses embryoscope+ for improved ivf treatments

Nov 18 2016

BRIEF-Vitrolife Q3 EBITDA profit narrows to SEK 71 mln

* Q3 operating income before depreciation and amortisation (EBITDA) amounted to SEK 71 (82) million Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Nov 03 2016

More From Around the Web

Earnings vs. Estimates